Affordable Access

Pharmacological studies of RGTA(11), a heparan sulfate mimetic polymer, efficient on muscle regeneration.

Authors
  • Meddahi, Anne
  • Brée, Françoise
  • Papy-Garcia, Dulce
  • Gautron, Jean
  • Barritault, Denis
  • Caruelle, Jean-Pierre
Type
Published Article
Journal
Journal of biomedical materials research
Publication Date
Dec 15, 2002
Volume
62
Issue
4
Pages
525–531
Identifiers
PMID: 12221700
Source
Medline
License
Unknown

Abstract

RGTA is a family of chemically modified polymers that have been engineered to mimic the properties of heparan sulfates towards heparin binding growth factors. In vivo, RGTA stimulated tissue repair and protection when injected at the site of an injury. These properties have been reported in various models, suggesting a potential interest for therapeutic uses as a general tissue repair agent. We have focused our interest on RGTA(11), a dextran derivative that was shown to enhance, after a unique and local administration, muscle regeneration after total crushing. We first show that a single RGTA(11) systemic administration can be as efficient as a local injection for stimulating muscle regeneration. Using an H(3)-labeled RGTA(11) we have measured some pharmacokinetic parameters. Distribution volume was 51.81 mL, clearance was about 2 mL/min, and half-life was 94 min, giving a total elimination time of 11 h. We also demonstrate that RGTA(11) remains detectable in the body only after tissue injury. It was detected by autoradiography in the crushed muscle just after injury and remained at least for a week. These results provide a rational explanation for the long lasting effect of a single local or systemic injection of RGTA.

Report this publication

Statistics

Seen <100 times